Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.

Jackson, C V

Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis. [electronic resource] - The Journal of pharmacology and experimental therapeutics May 1992 - 546-52 p. digital

Publication Type: Comparative Study; Journal Article

0022-3565


Animals
Anticoagulants--therapeutic use
Blood Coagulation--drug effects
Coronary Thrombosis--prevention & control
Dogs
Heparin--therapeutic use
Infusions, Intravenous
Models, Cardiovascular
Oligopeptides--blood
Partial Thromboplastin Time
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors--pharmacology
Prothrombin Time